Abstract
Osteoarthritis is a common joint disease characterized by damage to the joint cartilage that occurs throughout the entire joint tissue. This damage primarily manifests as pain in the affected area. In clinical practice, medication is commonly used to relieve pain, but the treatment’s effectiveness is poor and recurrent attacks are likely. Schisandrin B is the most abundant biphenylcyclohexene lignan found in the traditional Chinese medicine Schisandra chinensis, and it possesses various pharmacological effects. This study aims to investigate the protective effect of Schisandrin B on mitochondrial damage in osteoarthritis (C28I2 cells) under an inflammatory environment induced by LPS. Cell proliferation and activity, scratch tests, and LDH release tests are utilized to assess cell growth and migration ability. The immunofluorescence assay was used to detect the expression levels of proliferation and apoptosis proteins. The Western Blot assay was used to detect the expression levels of mitochondrial fusion and division proteins. The JC-1 assay was used to detect changes in mitochondrial membrane potential. The mitochondrial fluorescence probe assay was used to detect mitochondrial activity. Through research, it was found that Schisandrin B promotes the proliferation, growth, and migration of C28I2 cells, reduces apoptosis of C28I2 cells, balances mitochondrial fusion and division, stabilizes mitochondrial membrane potential, and promotes mitochondrial activity in an LPS induced inflammatory environment.
Graphical abstract
Similar content being viewed by others
Data Availability
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
References
Abdel-Aziz MA, Ahmed HMS, El-Nekeety AA, Abdel-Wahhab MA (2021) Osteoarthritis complications and the recent therapeutic approaches. Inflammopharmacology 29:1653–1667. https://doi.org/10.1007/s10787-021-00888-7
Abramoff B, Caldera FE (2020) Osteoarthritis: pathology, diagnosis, and treatment options. Med Clin N Am 104:293–311. https://doi.org/10.1016/j.mcna.2019.10.007
Adebayo M, Singh S, Singh AP, Dasgupta S (2021) Mitochondrial fusion and fission: the fine-tune balance for cellular homeostasis. FASEB J 35:e21620. https://doi.org/10.1096/fj.202100067R
Amir Al, Thierry AR (2023) Mitochondria-derived cell-to-cell communication. Cell Rep 42:112728. https://doi.org/10.1016/j.celrep.2023.112728
Andrieux P, Chevillard C, Cunha-Neto E, Nunes JPS (2021) Mitochondria as a Cellular Hub in Infection and Inflammation. Int J Mol Sci 22:11338. https://doi.org/10.3390/ijms222111338
Annesley SJ, Fisher PR (2019) Mitochondria in health and disease. Cells 8:680. https://doi.org/10.3390/cells8070680
Averbeck D, Rodriguez-Lafrasse C (2021) Role of mitochondria in radiation responses: epigenetic, metabolic, and signaling impacts. Int J Mol Sci 22:11047. https://doi.org/10.3390/ijms222011047
Bader V, Winklhofer KF (2020) Mitochondria at the interface between neurodegeneration and neuroinflammation. Semin Cell Dev Biol 99:163–171. https://doi.org/10.1016/j.semcdb.2019.05.028
Blanco FJ, Fernández-Moreno M (2020) Mitochondrial biogenesis: a potential therapeutic target for osteoarthritis. Osteoarthr Cartil 28:1003–1006. https://doi.org/10.1016/j.joca.2020.03.018
Chan DC (2020) Mitochondrial dynamics and its involvement in disease. Annu Rev Pathol 15:235–259. https://doi.org/10.1146/annurev-pathmechdis-012419-032711
Chen X, Xiao Z, Jiang Z, Jiang Y, Li W, Wang M (2021) Schisandrin B attenuates airway inflammation and airway remodeling in asthma by inhibiting NLRP3 inflammasome activation and reducing pyroptosis. Inflammation 44:2217–2231. https://doi.org/10.1007/s10753-021-01494-z
Cho Y, Jeong S, Kim H, Kang D, Lee J, Kang SB, Kim JH (2021) Disease-modifying therapeutic strategies in osteoarthritis: current status and future directions. Exp Mol Med 53:1689–1696. https://doi.org/10.1038/s12276-021-00710-y
Colletti A, Cicero AFG (2021) Nutraceutical approach to chronic osteoarthritis: from molecular research to clinical evidence. Int J Mol Sci 22:12920. https://doi.org/10.3390/ijms222312920
Coryell PR, Diekman BO, Loeser RF (2021) Mechanisms and therapeutic implications of cellular senescence in osteoarthritis. Nat Rev Rheumatol 17:47–57. https://doi.org/10.1038/s41584-020-00533-7
Ding M, Shu P, Gao S, Wang F, Gao Y, Chen Y, Deng W, He G, Hu Z, Li T (2018) Schisandrin B protects human keratinocyte-derived HaCaT cells from tert-butyl hydroperoxide-induced oxidative damage through activating the Nrf2 signaling pathway. Int J Mol Med 42:3571–3581. https://doi.org/10.3892/ijmm.2018.3901
Hawker GA, King LK (2022) The burden of osteoarthritis in older adults. Clin Geriatr Med 38:181–192. https://doi.org/10.1016/j.cger.2021.11.005
Hu XL, Guo C, Hou JQ, Feng JH, Zhang XQ, Xiong F, Ye WC, Wang H (2019) Stereoisomers of Schisandrin B are potent ATP competitive GSK-3β inhibitors with neuroprotective effects against Alzheimer’s disease: stereochemistry and biological activity. ACS Chem Neurosci 10:996–1007. https://doi.org/10.1021/acschemneuro.8b00252
Hunter DJ, Bierma-Zeinstra S (2019) Osteoarthritis. Lancet 393:1745–1759. https://doi.org/10.1016/S0140-6736(19)30417-9
Jiang Y (2022) Osteoarthritis year in review 2021: biology. Osteoarthr Cartil 30:207–215. https://doi.org/10.1016/j.joca.2021.11.009
Krako N, Pavlovic K, Jotic A, Lalic K, Stoiljkovic M, Lukic L, Milicic T, Macesic M, Stanarcic J, Lalic NM (2021) Targeting mitochondria in diabetes. Int J Mol Sci 22:6642. https://doi.org/10.3390/ijms22126642
Li YJ, Liu HT, Xue CJ, Xing XQ, Dong ST, Wang LS, Ding CY, Meng L, Dong ZJ (2020) The synergistic anti-tumor effect of schisandrin B and apatinib. J Asian Nat Prod Res 22:839–849. https://doi.org/10.1080/10286020.2019.1645131
Li B, Guan G, Mei L, Jiao K, Li H (2021) Pathological mechanism of chondrocytes and the surrounding environment during osteoarthritis of temporomandibular joint. J Cell Mol Med 25:4902–4911. https://doi.org/10.1111/jcmm.16514
Liu D, Cai ZJ, Yang YT, Lu WH, Pan LY, Xiao WF, Li YS (2022) Mitochondrial quality control in cartilage damage and osteoarthritis: new insights and potential therapeutic targets. Osteoarthr Cartil 30:395–405. https://doi.org/10.1016/j.joca.2021.10.009
Luo Y, Ma J, Lu W (2020) The significance of mitochondrial dysfunction in cancer. Int J Mol Sci 21:5598. https://doi.org/10.3390/ijms21165598
Molnar V, Matišić V, Kodvanj I, Bjelica R, Jeleč Ž, Hudetz D, Rod E, Čukelj F, Vrdoljak T, Vidović D, Starešinić M, Sabalić S, Dobričić B, Petrović T, Antičević D, Borić I, Košir R, Zmrzljak UP, Primorac D (2021) Cytokines and chemokines involved in osteoarthritis pathogenesis. Int J Mol Sci 22:9208. https://doi.org/10.3390/ijms22179208
Nasser MI, Zhu S, Chen C, Zhao M, Huang H, Zhu P (2020) A comprehensive review on Schisandrin B and its biological properties. Oxid Med Cell Longev 2020:2172740. https://doi.org/10.1155/2020/2172740
Nedunchezhiyan U, Varughese I, Sun AR, Wu X, Crawford R, Prasadam I (2022) Obesity, inflammation, and immune system in osteoarthritis. Front Immunol 13:907750. https://doi.org/10.3389/fimmu.2022.907750
Qi Y, Cheng X, Jing H, Yan T, Xiao F, Wu B, Bi K, Jia Y (2020) Comparative pharmacokinetic study of the components in Alpinia oxyphylla Miq.-Schisandra chinensis (Turcz.) Baill. herb pair and its single herb between normal and Alzheimer’s disease rats by UPLC–MS/MS. J Pharm Biomed Anal 177:112874. https://doi.org/10.1016/j.jpba.2019.112874
Rice SJ, Beier F, Young DA, Loughlin J (2020) Interplay between genetics and epigenetics in osteoarthritis. Nat Rev Rheumatol 16:268–281. https://doi.org/10.1038/s41584-020-0407-3
Sacitharan PK (2019) Ageing and osteoarthritis. Subcell Biochem 91:123–159. https://doi.org/10.1007/978-981-13-3681-2_6
Shi H, Tang H, Ai W, Zeng Q, Yang H, Zhu F, Wei Y, Feng R, Wen L, Pu P, He Q (2021) Schisandrin B antagonizes cardiotoxicity induced by pirarubicin by inhibiting mitochondrial permeability transition pore (mPTP) opening and decreasing cardiomyocyte apoptosis. Front Pharmacol 12:733805. https://doi.org/10.3389/fphar.2021.733805
Shi H, Yan Y, Yang H, Pu P, Tang H (2022) Schisandrin B diet inhibits oxidative stress to reduce ferroptosis and lipid peroxidation to prevent pirarubicin-induced hepatotoxicity. Biomed Res Int 2022:5623555. https://doi.org/10.1155/2022/5623555
Wu Y, Li ZC, Yao LQ, Li M, Tang M (2019) Schisandrin B alleviates acute oxidative stress via modulation of the Nrf2/Keap1-mediated antioxidant pathway. Appl Physiol Nutr Metab 44:1–6. https://doi.org/10.1139/apnm-2018-0251
Yan LS, Zhang SF, Luo G, Cheng BC, Zhang C, Wang YW, Qiu XY, Zhou XH, Wang QG, Song XL, Pan SY, Zhang Y (2022) Schisandrin B mitigates hepatic steatosis and promotes fatty acid oxidation by inducing autophagy through AMPK/mTOR signaling pathway. Metabolism 131:155200. https://doi.org/10.1016/j.metabol.2022.155200
Zhong G, Madry H, Cucchiarini M (2022) Mitochondrial genome editing to treat human osteoarthritis—a narrative review. Int J Mol Sci 23:1467. https://doi.org/10.3390/ijms23031467
Acknowledgements
Each author expresses his gratitude to their institutions for providing the opportunity to develop this manuscript. Sincere thanks go to the co-authors for their contribution. The authors sincerely thank the anonymous reviewers for the improvement in the quality of the manuscript.
Funding
This study was supported by Natural Science Foundation of Ningbo (2022J049).
Author information
Authors and Affiliations
Contributions
FH and WJH conducted experiments; FH writed the manuscript; HMX designed the study and revised the manuscript. All authors have read and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Hu, F., Hu, W. & Xu, H. Schisandrin B Alleviates LPS Induced Mitochondrial Damage in C28I2 Cells. J Membrane Biol 257, 107–114 (2024). https://doi.org/10.1007/s00232-023-00299-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00232-023-00299-5